Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
2
×
new york blog main
startups
aphelion capital
azacitidine
beta-thalassemia
biolinq
boston
boston blog main
boston top stories
continuous glucose monitoring
dacogen
deals
decitabine
diabetes
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
hikma
insulated genomic domains
jared tagney
jdrf
joshua windmiller
kaleido biosciences
lifesci venture partners
mahesh karande
medical device
merck
national top stories
new york top stories
omega therapeutics
panobinostat
richard young
robert gould
rudolf jaenisch
What
based
2
×
new
research
2
×
startup
adds
advance
aims
approach
biolinq
biosensor
biotech
called
debuts
developing
diabetes
drugs
epigenetic
epigenetics
field
flagship’s
glucose
including
investors
juvenile
medicines
million
monitoring
morning
omega
patch
raised
step
therapeutics
thursday
touting
york
Language
unset
Current search:
based
×
research
×
" national blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
